Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.59
0.10 (6.71%)
At close: Oct 06, 2025, 3:29 PM
Connect Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | -36.12M | -17.06M | -25.48M | -62.21M | -87.26M | -118.6M | -118.57M | -202.36M | -145.82M |
Depreciation & Amortization | 355K | 510K | 807.87K | 988K | 1.03M | 1.03M | 914.77K | 633.44K | 221.55K |
Stock-Based Compensation | 5.84M | 8.19M | 6.4M | 3.1M | 2.54K | 3.51K | 4.98K | 4.41K | 5.12K |
Other Working Capital | -2.09M | -12.45M | 1.62M | 12.72M | -393.48K | 3.35M | 136.79K | -3.06M | -723.65K |
Other Non-Cash Items | -161.87K | 27.13K | -89.2K | 2.17M | 12.91M | 11.6M | 1.55M | 108.73M | 108.13M |
Deferred Income Tax | n/a | n/a | n/a | -1.46M | -1.96M | 1.61M | 2.12M | n/a | n/a |
Change in Working Capital | 1.91M | -15.53M | -6.77M | 9.48M | -289.09K | 7.02M | 9.79M | 3.24M | -954.47K |
Operating Cash Flow | -28.17M | -23.86M | -25.13M | -47.93M | -75.57M | -97.33M | -98.5M | -84.73M | -39.09M |
Capital Expenditures | -615.08K | -748.08K | -444.33K | -294K | -2.74M | -4.2M | -2.06M | -7.39M | -7.08M |
Cash Acquisitions | -2.94M | -2.94M | 2.96M | 2.94M | -10.38K | 41.94K | 35.82K | n/a | n/a |
Purchase of Investments | -23.32M | -15.41M | -1.64M | -32.6M | -61.9M | -111.49M | -91.78M | -17.8M | -6.57M |
Sales Maturities Of Investments | 13.3M | 12.71M | 52.44M | 105.19M | 92.89M | 33.87M | 17.77M | 19.9M | 8.61M |
Other Investing Acitivies | 2.26M | 2.26M | -100.5K | -84K | 10.38K | -41.94K | -35.77K | -646.45 | 1.32K |
Investing Cash Flow | -10.59M | -3.26M | 53.36M | 75.16M | 28.25M | -81.82M | -76.07M | -5.29M | -5.03M |
Debt Repayment | 290K | 290K | -290K | -290K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -5.46K | -5.66K | -194.59 |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19K | -142K | 130.28K | 69.28K | -120.03K | -23.85K | -6.15M | -23.49M | -17.16M |
Financial Cash Flow | 433.42K | 393.42K | 5.28K | -246K | -254.97K | -89.51K | 1.01M | 204.64M | 203.8M |
Net Cash Flow | -39.02M | -2.95M | -52.61M | -79.59M | -60.55M | -188.66M | -171.68M | 113.96M | 159.61M |
Free Cash Flow | -28.78M | -24.3M | -25.26M | -48.22M | -78.32M | -101.53M | -100.56M | -92.12M | -46.17M |